Rethinking cannabis risk screening for medical users
Examining the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Moderate Risk Cannabis Use Threshold Among a Sample of U.S. Military Veterans with Chronic Pain Who Report Medical Cannabis Use.
AI Summary
This study examined whether the standard ASSIST screening threshold accurately identifies moderate-risk cannabis use in 501 U.S. military veterans with chronic pain who used cannabis for medical reasons while receiving long-term opioid therapy. Researchers compared ASSIST scores with the Cannabis Use Disorder Identification TestβRevised (CUDIT-R), a cannabis-focused screening measure.
The currently recommended ASSIST cutoff of 4 performed poorly in this group. A cutoff of 7 produced the best overall discrimination, while a cutoff of 6 identified more people who may be at risk. The authors suggest using 7 for ongoing monitoring and 6 for initial screening, but emphasize that the ASSIST still has important limitations for detecting cannabis-related harms in medical cannabis users. Population-specific screening tools are needed.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Pain research papers you might find interesting.
Interviews explore how adults with regular pain perceive cannabis use
An 18-month cohort found adverse outcomes were infrequent, but long-term risksβ¦
Language models can extract documented cannabis use, but need validation
Explore More Research
Stay informed about the latest cannabis science.